CAMT:TASECamtek Ltd Analysis
Data as of 2026-05-25 - not real-time
$167.37
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Camtek Ltd. (CAMT) is trading at $167.37, notably below its 20‑day simple moving average of 180.20 and its 50‑day SMA of 174.30, suggesting recent price weakness despite a bullish overall trend direction. The 14‑day RSI sits at 45.8, edging into oversold territory, while the MACD histogram sits at –3.63 with a bearish signal line, reinforcing short‑term downside pressure. Yet the broader market sentiment is extremely optimistic, as reflected by a Fear‑Greed Index of 91.8 (“Extreme Greed”) and a bullish trend direction flag.
Fundamentally, CAMT exhibits a mixed profile: revenue reached $499.1 M with a modest 2.5 % YoY growth and healthy gross (≈51 %) and operating (≈22 %) margins, but earnings remain thin (trailing EPS $0.97) driving an astronomically high trailing P/E of 172.5 versus an industry average of 39.5, indicating the stock is markedly overvalued on current earnings. The forward P/E of 37 is more reasonable, implying analysts expect earnings acceleration. The balance sheet shows a strong cash position ($670 M) offset by substantial debt ($488 M) and a debt‑to‑equity of 71.5, suggesting leverage risk, while ROE (7.6 %) and ROA (7.1 %) are modest.
Risk metrics underscore heightened volatility: a 30‑day price swing of roughly 79 %, beta above 1.6, and a max drawdown of –27 %, all against a support level of 147.57 and resistance near 216.0. Liquidity appears adequate with an average 10‑day volume of 682 K, yet the stock’s high beta and volatility, combined with a lack of dividend, amplify price‑risk exposure. Given the bullish technical bias in the longer term but bearish short‑term signals, the stock sits at a crossroads where momentum traders may view it as a near‑term sell, while value‑oriented investors could anticipate upside if earnings improve.
Fundamentally, CAMT exhibits a mixed profile: revenue reached $499.1 M with a modest 2.5 % YoY growth and healthy gross (≈51 %) and operating (≈22 %) margins, but earnings remain thin (trailing EPS $0.97) driving an astronomically high trailing P/E of 172.5 versus an industry average of 39.5, indicating the stock is markedly overvalued on current earnings. The forward P/E of 37 is more reasonable, implying analysts expect earnings acceleration. The balance sheet shows a strong cash position ($670 M) offset by substantial debt ($488 M) and a debt‑to‑equity of 71.5, suggesting leverage risk, while ROE (7.6 %) and ROA (7.1 %) are modest.
Risk metrics underscore heightened volatility: a 30‑day price swing of roughly 79 %, beta above 1.6, and a max drawdown of –27 %, all against a support level of 147.57 and resistance near 216.0. Liquidity appears adequate with an average 10‑day volume of 682 K, yet the stock’s high beta and volatility, combined with a lack of dividend, amplify price‑risk exposure. Given the bullish technical bias in the longer term but bearish short‑term signals, the stock sits at a crossroads where momentum traders may view it as a near‑term sell, while value‑oriented investors could anticipate upside if earnings improve.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below SMA20
- bearish MACD histogram
- RSI under 50
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- forward PE 37
- revenue growth 2.5%
- strong cash position
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- industry positioning in semiconductor equipment
- high gross margin
- strategic product portfolio
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin9.63%
P/E Ratio172.5
ROE7.56%
ROA7.08%
Debt/Equity71.47
P/B Ratio11.3
Industry P/E39.5
Technical Analysis
TrendBullish
RSI45.8
Support$147.57
Resistance$215.99
MA 20$180.20
MA 50$174.30
MA 200$132.01
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8
Valuation
Target Price$187.25
Upside/Downside11.88%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.25
Volatility79.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.